Atlas Trials

CHA University

52 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CHA University

RecordFirmDate
Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy (NCT07493668)CHA University2026-05-14
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults (NCT07695441)CHA University2026-03-17
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes (NCT07692802)CHA University2026-03-02
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma (NCT07143812)CHA University2025-10-23
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer (NCT07151118)CHA University2025-09-01
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC (NCT07142226)CHA University2025-09-01
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial (NCT07027891)CHA University2025-07-01
Medipixel XA-Assisted PCI in Coronary Artery Disease (NCT06985693)CHA University2025-05-15
Carbohydrate Mouth Rinsing and Cognitive Response During Exercise (NCT07099807)CHA University2025-02-28
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy (NCT06815042)CHA University2025-02-01
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer (NCT06893380)CHA University2024-10-01
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab (NCT06648057)CHA University2024-09-23
MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study (NCT06543082)CHA University2024-08-05
RCVR (Residual CardioVascular Risk) Prospective Study (NCT06619353)CHA University2024-06-17
Development of the Neuroimaging Biomarker-based Prediction Model of Anxiety-related Disorders: Effect of Mindfulness-based Cognitive Therapy Using Neuroscience on the Brain (NCT05911412)CHA University2023-09-01
Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients (NCT05768256)CHA University2023-03-28
Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma (NCT05677217)CHA University2023-03-20
Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients (NCT06078605)CHA University2022-09-16
Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr (NCT05421650)CHA University2022-08-01
ROMIAE (Rule-Out Acute Myocardial Infarction Using Artificial Intelligence Electrocardiogram Analysis) Trial (NCT05435391)CHA University2022-03-16
Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis (NCT05136560)CHA University2022-03-01
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC (NCT05134532)CHA University2021-12-24
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy (NCT05197504)CHA University2021-12-20
Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive (NCT06078592)CHA University2021-10-08
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab (NCT05173298)CHA University2021-08-02
Comparison of Focused ESWT by Frequency for Patients With Myofascial Pain Syndrome (NCT04998630)CHA University2021-06-22
The Influence of Infant Feeding Type on Preterm Infant's Intestinal Microbiome (NCT04972214)CHA University2021-05-17
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC (NCT04862949)CHA University2021-05-01
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer (NCT04871321)CHA University2021-04-14
Changes in Shoulder Muscle Activation According to the Methods of Carrying Backpacks (NCT04879901)CHA University2021-03-09
Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients (NCT04657315)CHA University2020-06-24
Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP) (NCT04303884)CHA University2020-06-01
Online Mental Health Program for Female College Students (NCT04982523)CHA University2020-04-27
Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost (NCT04743622)CHA University2019-04-30
Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial (NCT04647461)CHA University2019-03-20

Track CHA University automatically

Every clearance here is in the API, with alerts when new ones post.